Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China
NCT04853238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1507
Last updated 2024-12-06
Summary
This observational study will be conducted in COPD participants in Tier 2 and 3 hospitals in China to gain an understanding of the complex COPD management and physician's treatment strategy.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- OTHER
-
Prospective observational cohort study
Prospective observational cohort study. No study treatment was administered in this study.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-27
- Primary Completion
- 2022-11-03
- Completion
- 2023-02-06
Countries
- China
Study Locations
More Related Trials
-
Perception of Symptom Variability in COPD
NCT01753427 ·Status: COMPLETED
-
Early COPD for China Pulmonary Health Study Stage II
NCT05028985 ·Status: RECRUITING
-
The China National COPD Screening Program
NCT05480176 ·Status: RECRUITING
-
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
NCT03151395 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD
NCT06172777 ·Status: COMPLETED
-
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
NCT06074042 ·Status: RECRUITING
-
A Cohort of Patients With Chronic Pulmonary Disease
NCT04050943 ·Status: UNKNOWN
-
Air Pollution and Health of COPD Patients
NCT05076630 ·Status: COMPLETED
-
Predictive Value of Inflammatory Biomarkers and FEV1 for COPD
NCT03532893 ·Status: COMPLETED
-
Lung Health of Early COPD: A Multi-center Cohort Study
NCT05466396 ·Status: RECRUITING
-
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
NCT06724848 ·Status: RECRUITING
-
Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT03170999 ·Status: COMPLETED
-
Small Bioactive Molecules in Early COPD Diseases
NCT04950023 ·Status: UNKNOWN
-
Characterisation of People With COPD
NCT01263340 ·Status: COMPLETED
-
A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China
NCT02600221 ·Status: COMPLETED
-
Lung and Gut Microbiome in Chronic Obstructive Pulmonary Disease
NCT03310164 ·Status: COMPLETED
-
Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic
NCT04948216 ·Status: COMPLETED
-
GIRH Chronic Obstructive Pulmonary Disease Observational Study
NCT03893409 ·Status: UNKNOWN
-
Quality Control for Chronic Obstructive Pulmonary Disease
NCT03604146 ·Status: COMPLETED
-
Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China
NCT03187236 ·Status: UNKNOWN
-
Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD
NCT01254032 ·Status: COMPLETED
-
The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients
NCT04905420 ·Status: COMPLETED
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD
NCT03010592 ·Status: UNKNOWN
-
Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00292552 ·Status: COMPLETED